cAMP ELISA Assay Kit (Fluorescence)
|
Catalog Number:
CA-C315
|
Detailed Description
|
CA-C315
|
|
Name
|
Elite™ cAMP ELISA Kit (Fluorescence)
|
|
Description
|
Elite™ cAMP ELISA Kit provides a sensitive method for detecting adenylate cyclase activity in biochemical or cell-based assay system. Compared with other cAMP ELISA kits, our kit eliminates the tedious acetylation step. The kit uses Elite™ Red as a fluorimetric substrate to quantify the HRP activity. The high sensitivity (for as low as 0.1 nM) makes it superior to any other known colorimetric-based or fluorescence-based kits in the market.
|
|
Application
|
The assay can be conveniently performed in a 96-well microtiter-plate format and can be easily adapted to automation. The fluorescent product formed is proportional to the activity of the HRP-cAMP conjugate.
|
|
Sensitivity
|
0.1 pmol/mL to 10 pmol/mL; EC50 = 1.6 pmol/mL
|
|
Size
|
1 plate (96-well)
|
|
Detection
|
Fluorescence microplate reader
|
|
For Downloading
|
===> DATA SHEET ===> MSDS
|
About the Elite™ cAMP ELISA Assay Kit (Fluorescence)
Cyclic adenosine monophosphate (cAMP) is one of the most important intracellular second messengers and plays a central role in signal transduction pathways regulated by G protein-coupled receptors (GPCRs), hormones, neurotransmitters, and growth factors. Activation of adenylate cyclase leads to the conversion of ATP into cAMP, which subsequently regulates protein kinase A (PKA), cyclic nucleotide-gated ion channels, exchange proteins directly activated by cAMP (EPAC), and downstream gene transcription pathways. Because cAMP signaling is involved in numerous physiological processes including metabolism, immune regulation, cardiovascular function, neuronal signaling, and cell proliferation, quantitative measurement of intracellular cAMP levels is widely used in basic research, drug discovery, and GPCR screening applications.
eEnzyme's Elite™ cAMP ELISA Assay Kit (Fluorescence) provides a sensitive and convenient method for measuring cAMP levels in biochemical and cell-based assay systems. The kit utilizes a competitive immunoassay format in which endogenous cAMP competes with labeled cAMP for binding to a cAMP-specific antibody. Fluorescent detection provides high sensitivity and a broad dynamic range for accurate quantification of intracellular cAMP concentrations. Compared with many conventional cAMP ELISA methods, the assay eliminates the need for tedious acetylation procedures, simplifying workflow and reducing assay time while maintaining excellent sensitivity.
The Elite™ cAMP ELISA Assay Kit is suitable for monitoring GPCR activation, adenylate cyclase activity, receptor pharmacology, compound screening, and signal transduction studies. The assay can be used to evaluate agonists, antagonists, inverse agonists, and allosteric modulators that regulate cAMP signaling pathways. Its robust performance and compatibility with high-throughput screening formats make it an ideal tool for pharmaceutical research, receptor characterization, drug discovery, and cellular signaling investigations.
Applications of the cAMP ELISA Assay Kit
• GPCR signaling and receptor pharmacology studies • Adenylate cyclase activity measurement • Agonist and antagonist screening • Drug discovery and high-throughput screening • Cell signaling and signal transduction research • Hormone and neurotransmitter response studies • Compound potency and efficacy determination • Functional characterization of Gs- and Gi-coupled receptors
Biological Significance of cAMP Signaling
cAMP functions as a universal intracellular second messenger that transmits signals from activated cell-surface receptors to downstream effector pathways. Changes in intracellular cAMP concentrations regulate numerous biological processes including metabolism, insulin secretion, cardiac contractility, neurotransmission, immune responses, and gene expression. Many therapeutically important GPCRs exert their biological effects through modulation of cAMP production, making cAMP measurement one of the most widely used functional readouts in receptor pharmacology and drug discovery. Because alterations in cAMP signaling are associated with metabolic disorders, cardiovascular disease, inflammatory conditions, neurological disorders, and cancer, quantitative cAMP assays provide valuable tools for investigating disease mechanisms and identifying novel therapeutic candidates.
Selected Citations: 1. GPR101 mediates the pro-resolving actions of RvD5 n-3 DPA in arthritis and infections. J. Clin. Invest. 130, 359–373 (2020). 2. Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress. BMC Complement. Altern. Med. 17, 1–12 (2017). 3. Novel resolvin D2 receptor ais in infectious inflammation. J. Immunol. 198, 842–851 (2017).
Background Reading: Novel Resolvin D2 Receptor Axis in Infectious Inflammation
|
|
|